Terumo recalls two cardiovascular procedure kits (catalog #76645 & 73806) due to potential shipping damage. Affected kits may have packaging issues that could impact use.
“Terumo Cardiovascular Kit Shipping Damage Risk - Recalled Products.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/61185-terumo-cardiovascular-kit-shipping-damage-risk-recalled-products. Based on FDA recall #Z-0949-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0949-2022%22&limit=1).
The FDA announced on Feb. 3, 2022, that Terumo Cardiovascular Systems Corp voluntarily recalled Cardiovascular Procedure Kits due to potential packaging damage from shipping. The agency issued recall number Z-0949-2022 for the affected devices.
Lot #Z15957677, case label GTIN: (01)00699753507685, product identifier: (17)230228(10)Z15957677
Lot #Z16958398, case label GTIN: (01)00699753477728, product identifier: (17)230228(10)Z16958398
UPC 00699753477728
UPC 00699753507685
Sold nationwide in the states of CA and IN
The hazard
The recall addresses potential damage to Cardiovascular Procedure Kit packaging that occurred during shipping, according to the FDA.
Context
GovInfoNow's records show Terumo Cardiovascular Systems Corp has one other recall on record since Dec. 18, 2017, involving possible blood leaks in LeukoGuard Filters. Other recent recalls of similar products include Medline Medical Procedure Kits: Catheter Issues Recalled (May 4, 2026), Windstone AMS Medical Kits: Lidocaine Injection Recall Due to Supplier Quality Issues (June 17, 2026), and Medline Convenience Kits Recall: Risk of Sterile Packaging Breach (June 12, 2026).
How to tell if you have this one
Check for catalog numbers 76645 or 73806 on the kit. Look for lot numbers Z15957677 or Z16958398 on the packaging.
Look for catalog numbers 76645 or 73806 and lot numbers Z15957677 or Z16958398 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide; the notice names 2 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “US Nationwide distribution in the states of CA and IN.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: California, Indiana.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0949-2022 (February 3, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0949-2022 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.